Cargando…
Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections
INTRODUCTION: In secondary immunodeficiency, immunoglobulin replacement therapy (IgRT) is recommended by guidelines (GL) for patients with IgG level < 4 g/l and more than 3 infections or a severe infection. IgRT may be appropriate if IgG level < 4 g/l and/or 1–3 less severe infections (≤ grade...
Autores principales: | Link, Hartmut, Kerkmann, Markus, Holtmann, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046374/ https://www.ncbi.nlm.nih.gov/pubmed/35257229 http://dx.doi.org/10.1007/s00520-022-06920-y |
Ejemplares similares
-
G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey
por: Link, Hartmut, et al.
Publicado: (2018) -
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany
por: Link, Hartmut, et al.
Publicado: (2019) -
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
por: Visentin, Andrea, et al.
Publicado: (2022) -
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021) -
The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia
Publicado: (1981)